| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A novel immunoregulatory axis of NKT cell subsets regulating tumor immunity
|
Berzofsky, Jay A.
|
|
2008
|
57 |
11 |
p. 1679-1683
|
artikel
|
| 2 |
Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity
|
Ménard, Cédric
|
|
2008
|
57 |
11 |
p. 1579-1587
|
artikel
|
| 3 |
Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity
|
Ménard, Cédric
|
|
|
57 |
11 |
p. 1579-1587
|
artikel
|
| 4 |
Cancer treatment: the combination of vaccination with other therapies
|
Andersen, Mads Hald
|
|
2008
|
57 |
11 |
p. 1735-1743
|
artikel
|
| 5 |
Combination of two fiber-mutant adenovirus vectors, one encoding the chemokine FKN and another encoding cytokine interleukin 12, elicits notably enhanced anti-tumor responses
|
Gao, Jian-Qing
|
|
2008
|
57 |
11 |
p. 1657-1664
|
artikel
|
| 6 |
Cooperation of adenosine and prostaglandin E2 (PGE2) in amplification of cAMP–PKA signaling and immunosuppression
|
Su, Yunyun
|
|
2008
|
57 |
11 |
p. 1611-1623
|
artikel
|
| 7 |
Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia
|
Palma, M.
|
|
2008
|
57 |
11 |
p. 1705-1710
|
artikel
|
| 8 |
Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen
|
Croce, Michela
|
|
2008
|
57 |
11 |
p. 1625-1634
|
artikel
|
| 9 |
Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer
|
Williams, Benjamin B.
|
|
2008
|
57 |
11 |
p. 1635-1645
|
artikel
|
| 10 |
Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells
|
Stoitzner, Patrizia
|
|
2008
|
57 |
11 |
p. 1675
|
artikel
|
| 11 |
Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells
|
Stoitzner, Patrizia
|
|
2008
|
57 |
11 |
p. 1665-1673
|
artikel
|
| 12 |
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration
|
Boullart, A. C. Inge
|
|
2008
|
57 |
11 |
p. 1589-1597
|
artikel
|
| 13 |
Molecular mechanisms of MHC class I abnormalities and APM components in human tumors
|
Seliger, Barbara
|
|
2008
|
57 |
11 |
p. 1719-1726
|
artikel
|
| 14 |
Oncoantigens as anti-tumor vaccination targets: the chance of a lucky strike?
|
Calogero, Raffaele Adolfo
|
|
2008
|
57 |
11 |
p. 1685-1694
|
artikel
|
| 15 |
Optimized DNA vaccines to specifically induce therapeutic CD8 T cell responses against autochthonous breast tumors
|
Cho, Hyun-Il
|
|
2008
|
57 |
11 |
p. 1695-1703
|
artikel
|
| 16 |
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
|
Bennouna, Jaafar
|
|
2008
|
57 |
11 |
p. 1599-1609
|
artikel
|
| 17 |
Progress in Vaccination against Cancer 2007 (PIVAC 7)
|
|
|
2008
|
57 |
11 |
p. 1677
|
artikel
|
| 18 |
Protein-bound polysaccharide K augments IL-2 production from murine mesenteric lymph node CD4+ T cells by modulating T cell receptor signaling
|
Asai, Hirobumi
|
|
2008
|
57 |
11 |
p. 1647-1655
|
artikel
|
| 19 |
Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations
|
Aptsiauri, Natalia
|
|
2008
|
57 |
11 |
p. 1727-1733
|
artikel
|
| 20 |
The “A, B and C” of Her-2 DNA vaccine development
|
Wei, Wei-Zen
|
|
2008
|
57 |
11 |
p. 1711-1717
|
artikel
|
| 21 |
The “A, B and C” of Her-2 DNA vaccine development
|
Wei, Wei-Zen
|
|
|
57 |
11 |
p. 1711-1717
|
artikel
|
Tijdschrift beschrijving